DISCLOSURE UNDER REGULATION 7(2) OF SEBI (PROHIBITION OF INSIDER TRADING) REGULATIONS, 2015
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sudhir Sethi, the main Promoter and Director of Beryl Drugs Ltd (DIN: 00090172), has bought 15,000 equity shares of the company through an on-market purchase on March 13, 2026. This acquisition represents 0.29% of the company's share capital. As a result, his total holding has increased from 4,55,143 shares (18.98%) to 4,70,143 shares (19.27%). The disclosure was filed under SEBI's Insider Trading Regulations, as required for promoter share purchases.
This is a small insider buy by the promoter, which is generally viewed as a mildly positive signal showing promoter confidence in the company. However, the size of the purchase (just 0.29%) is too small to materially shift shareholder sentiment or drive significant stock price movement.